zealand_logo_RGB_01.png
Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons
April 19, 2023 16:00 ET | Zealand Pharma
Company announcement – No. 16 / 2023 Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons ...
zealand_logo_RGB_01.png
Zealand Pharma launches long-term incentive program for Zealand’s Board of Directors, Corporate Management and employees for 2023
April 19, 2023 15:45 ET | Zealand Pharma
Company announcement – No. 15 / 2023 Zealand Pharma launches long-term incentive program for Zealand’s Board of Directors, Corporate Management and employees for 2023 Copenhagen, Denmark,...
zealand_logo_RGB_01.png
Zealand Pharma to Participate in 22nd Annual Needham Virtual Healthcare Conference
April 12, 2023 11:00 ET | Zealand Pharma
Press release – No. 2 / 2023 Zealand Pharma to Participate in 22nd Annual Needham Virtual Healthcare Conference Copenhagen, Denmark, April 12, 2023 – Zealand Pharma A/S (Nasdaq...
zealand_logo_RGB_01.png
Zealand Pharma completes registration of capital increase
April 04, 2023 02:32 ET | Zealand Pharma
Company announcement – No. 14 / 2023 Zealand Pharma completes registration of capital increase NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN OR INTO THE UNITED STATES,...
zealand_logo_RGB_01.png
Zealand Pharma A/S publishes a listing prospectus regarding admission to trading and official listing of 6,578,948 new shares on Nasdaq Copenhagen
April 03, 2023 03:29 ET | Zealand Pharma
Company announcement – No. 13 / 2023 Zealand Pharma A/S publishes a listing prospectus regarding admission to trading and official listing of 6,578,948 new shares on Nasdaq Copenhagen NOT FOR...
zealand_logo_RGB_01.png
Total number of shares and voting rights in Zealand Pharma at March 31, 2023
March 31, 2023 11:05 ET | Zealand Pharma
Company announcement – No. 12 / 2023 Total number of shares and voting rights in Zealand Pharma at March 31, 2023 Copenhagen, Denmark, March 31, 2023 – Zealand Pharma A/S (“Zealand”)...
zealand_logo_RGB_01.png
Zealand Pharma announces completion of a directed issue and private placement of 6,578,948 million new ordinary shares raising gross proceeds of DKK 1.5 billion
March 30, 2023 16:45 ET | Zealand Pharma
Company announcement – No. 11 / 2023 Zealand Pharma announces completion of a directed issue and private placement of 6,578,948 million new ordinary shares raising gross proceeds of DKK 1.5...
zealand_logo_RGB_01.png
Zealand Pharma announces directed issue and private placement of approximately 6.5 million new shares
March 30, 2023 11:01 ET | Zealand Pharma
Company announcement – No. 10 / 2023 Zealand Pharma announces directed issue and private placement of approximately 6.5 million new shares NOT FOR RELEASE, PUBLICATION OR...
zealand_logo_RGB_01.png
Zealand Pharma's Annual General Meeting 2023
March 29, 2023 14:00 ET | Zealand Pharma
Company announcement – No. 9 / 2023 Zealand Pharma's Annual General Meeting 2023 Copenhagen, March 29, 2023 - Today, Zealand Pharma A/S ("Zealand") (NASDAQ: ZEAL) (CVR no. 20 04 50 78), held...
zealand_logo_RGB_01.png
Zealand Pharma Increases its Share Capital as a Consequence of Exercise of Employee Warrants
March 28, 2023 16:00 ET | Zealand Pharma
Company announcement – No. 8 / 2023 Zealand Pharma Increases its Share Capital as a Consequence of Exercise of Employee Warrants Copenhagen, Denmark, March 28, 2023 – Zealand Pharma A/S...